Cytological Findings in Conservative Treatment of Prostatic Cancer
Treatment response in the case of prostatic cancer may sometimes be difficult to assess. It should be emphasised that response criteria must be objective, quickly carried out, easily repeatable and with a favourable cost-benefit ratio. On the other hand, a precise evaluation of cancer patients on conservative treatment is well-recognised to be important in order to decide in good time whether current therapy should be continued or modified.
KeywordsProstatic Cancer Prostatic Carcinoma Aspiration Biopsy Cytological Finding Clinical Disease Progression
Unable to display preview. Download preview PDF.
- 6.Leistenschneider W, Nagel R (1984) Control of response to extramustine phosphate therapy through cytology and DNA analysis of cell nuclei in prospective study. Eur Urol 23(6):81–88Google Scholar
- 7.Dohm G, Honbach C (1984) Pathology and classification of prostate malignancies: experience of the German Prostate Cancer Registry. In: Jacobi GH, Hoenfellner R (eds) Prostate cancer. International perspectives in urology, vol 3. Williams and Wilkins, Baltimore, pp 95–113Google Scholar
- 8.Bandhauer K (1983) Value of cytology for follow-up of prostatic cancer after contrasexual and irradiation therapy. Prostate 4 (4):428Google Scholar
- 9.Frankel JM, Scardino PT, Carlton EC (1983) The accurate predictive value of the late prostate exam and biopsy in prostatic cancer treated with radiotherapy. Abstract 299, AUA Meeting, Las Vegas, 17–21 April, 1983Google Scholar
- 12.Scardino PT, Wheler TM (1985) Prostatic biopsy after irradiation therapy for prostatic cancer. Urology 25 (Suppl) (2) 39–46Google Scholar
- 13.Ackerman LV, Del Regato JA (1970) Radiation therapy in the treatment of carcinoma of the prostate. In: Cancer, 4th edn. Mosby, St Louis, p 79Google Scholar
- 15.Schmeller JD, Laible V, Leick H (1984) Aspiration cytology of prostatic carcinoma following endocrine therapy. Abstract 551, AUA Meeting, New Orleans, 6–10 May, 1984Google Scholar